Sanità internazionale 23 Settembre 2016 11:34

Telemedicine in France, the FHF : «Practice in development but we need more funding»

Patients better diagnosed before going to the hospital and better assisted after having come back  home. The telemedicine means all this. For this reason it is developing more and more in France, after having been experimented in different ways. A few days from the presentation (23 September) of the 2017 Social Security Financing Bills by […]

Patients better diagnosed before going to the hospital and better assisted after having come back  home. The telemedicine means all this. For this reason it is developing more and more in France, after having been experimented in different ways. A few days from the presentation (23 September) of the 2017 Social Security Financing Bills by the Government, the Hospital Federation of France (FHF) and the lobby of the state hospitals boost for obtaining funding and developing the use of the telemedicine.

The FHF asks that these acts of medicine effectuated at distance could be remunerated as the traditional ones. The absence of the medical expenses cover for this kind of practice represents an obstacle to its spread on the French territory. «If the medical acts effectuated at distance won’t get any financial value, the hospitals won’t have visibility to develop the telemedicine», David Gruson has affirmed, the FHF General Delegate. The first result of the experiments of assistance at distance, started in 2014, are going to be presented on 30 September by the High Authority of Health.

GLI ARTICOLI PIU’ LETTI
Advocacy e Associazioni

Porpora trombotica trombocitopenica. ANPTT Onlus celebra la III Giornata nazionale

Evento “WeHealth” promosso in partnership con Sanofi e in collaborazione con Sics Editore per alzare l’attenzione sulla porpora trombotica trombocitopenica (TTP) e i bisogni ancora i...
Salute

Tumori: boom di casi nei paesi occidentali. Cinieri (Aiom): “Prevenzione attiva per ridurre carico della malattia”

Nel 2024 negli USA, per la prima volta nella storia, si supera la soglia di 2 milioni di casi di tumore. Una crescita importante, comune a tutti i Paesi occidentali. Per Saverio Cinieri, presidente di...
Salute

Tumore del polmone non a piccole cellule di stadio precoce e avanzato: lo stato dell’arte di nivolumab

Sono stati presentati al recente Congresso ASCO gli aggiornamenti degli studi relativi all’impiego di nivolumab nel tumore del polmone non a piccole cellule di stadio precoce e avanzato. Il quad...
Advocacy e Associazioni

Cirrosi epatica, i pazienti chiedono meno burocrazia e maggior accesso al teleconsulto

Nella nuova puntata di The Patient Voice, Ivan Gardini (EpaC Ets), Ilenia Malavasi (Affari Sociali) e Francesca Ponziani (Pol. Gemelli)